Foundation Medicine testing was performed on her tumor and revealed a tumor mutational burden (TMB) of 1 mut/Mb, and alterations in ERBB2, CDK12, TP53, PRKCI, RAD21, SDHA, and TERC. This evidence concerns the gene RAD21 and neoplasm.